Literature DB >> 26810177

Immediate and Delayed Hypersensitivity Reactions to Proton Pump Inhibitors: Evaluation and Management.

Iris M Otani1, Aleena Banerji2.   

Abstract

PPIs are among the most commonly administered medications in the USA and are generally well tolerated. Immediate and delayed immune-mediated hypersensitivity reactions are rare but increasingly recognized adverse effects of proton pump inhibitors (PPIs). Immediate hypersensitivity reactions can occur due to IgE-mediated hypersensitivity to PPIs and can be evaluated by immediate hypersensitivity skin testing and oral provocation challenge testing. A desensitization protocol can be used when PPI use cannot be avoided in an allergic patient. Delayed hypersensitivity reactions to PPIs have also been reported. Occupational exposures causing cutaneous reactions to PPIs are the most commonly reported delayed hypersensitivity reaction, followed by drug-induced subacute cutaneous lupus erythematosus. This review presents a summary of the clinical presentation, diagnostic evaluation, and management of immune-mediated hypersensitivity reactions to PPIs.

Entities:  

Keywords:  Adverse drug reaction; Drug allergy; Hypersensitivity reaction; PPI; Patch testing; Proton pump inhibitor; Skin testing

Mesh:

Substances:

Year:  2016        PMID: 26810177     DOI: 10.1007/s11882-016-0595-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  45 in total

1.  Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test.

Authors:  Patrizia Bonadonna; Carla Lombardo; Oscar Bortolami; Andreas Bircher; Kathrin Scherer; Annick Barbaud; Giovanni Passalacqua; Mauro Pagani
Journal:  J Allergy Clin Immunol       Date:  2012-06-22       Impact factor: 10.793

2.  Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.

Authors:  L M Toms-Whittle; L H John; D A Buckley
Journal:  Clin Exp Dermatol       Date:  2010-08-25       Impact factor: 3.470

3.  Study of cross-reactivity between proton pump inhibitors.

Authors:  M T Sobrevia Elfau; M Garcés Sotillos; L Ferrer Clavería; N Segura Arazuri; S Monzón Ballarin; C Colás Sanz
Journal:  J Investig Allergol Clin Immunol       Date:  2010       Impact factor: 4.333

4.  Widespread Scaly Eruption in a Patient With Multiple Comorbidities.

Authors:  Elizabeth K Jones; Nina Mingioni; Jason B Lee
Journal:  JAMA       Date:  2015-10-27       Impact factor: 56.272

5.  Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases.

Authors:  Annick Bracke; Tamar Nijsten; Johan Vandermaesen; Lieve Meuleman; Julien Lambert
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

6.  Anaphylactic reaction to omeprazole.

Authors:  Efthalia Christodoulos Stefanaki; Vasilios Vovolis; Ioanna Letsa; Nikolaos Koutsostathis
Journal:  Am J Gastroenterol       Date:  2008-06       Impact factor: 10.864

7.  Occupational contact allergy to omeprazole and fluoxetine.

Authors:  Pere Sanz-Gallén; Santiago Nogué; Inmaculada Herrera-Mozo; George L Delclos; Antonio Valero
Journal:  Contact Dermatitis       Date:  2011-08       Impact factor: 6.600

8.  Occupational contact dermatitis caused by omeprazole in a veterinary medicament.

Authors:  Wisam Alwan; Piu Banerjee; Ian R White
Journal:  Contact Dermatitis       Date:  2014-12       Impact factor: 6.600

9.  Anaphylaxis to omeprazole: diagnosis and desensitization protocol.

Authors:  Ronit Confino-Cohen; Arnon Goldberg
Journal:  Ann Allergy Asthma Immunol       Date:  2006-01       Impact factor: 6.347

10.  Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors.

Authors:  T Lobera; B Navarro; M D Del Pozo; I González; A Blasco; R Escudero; M Venturini; E Alarcón
Journal:  J Investig Allergol Clin Immunol       Date:  2009       Impact factor: 4.333

View more
  3 in total

1.  Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease.

Authors:  Nam-Jun Cho; Chi-Young Choi; Samel Park; Sang-Ho Park; Eun Young Lee; Hyo-Wook Gil
Journal:  Kidney Res Clin Pract       Date:  2018-03-31

2.  Drug rash with eosinophilia and systemic symptoms and severe renal injury induced by proton pump inhibitor therapy: A case report.

Authors:  Qien He; Guanghui Ying; Xiapei Fei; Chenqin Zha; Zhaogui Chen; Yishu Bao; Jiaorong Long; Zhujun Wang; Xuelin He; Min Xia
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

Review 3.  The important role of non-covalent drug-protein interactions in drug hypersensitivity reactions.

Authors:  Werner J Pichler
Journal:  Allergy       Date:  2021-06-14       Impact factor: 14.710

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.